This ticker has not been starred yet GILD Gilead Sciences, Inc.
Biological Products (no Diagnostic Substances)
Book value per $ invested $ 0.14
Leverage 64.69%
Market Cap $ 141.0B
PE 22.41
Dividend Yield 2.75%
Profit $ 6.3B
Margin 21.66%

Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV, hepatitis B, hepatitis C, and influenza, including Harvoni and Sovaldi.

Subscribe Now For Access - Only $1.99 Per Month